Navigation Links
InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
Date:4/1/2008

mation available to InterMune as of the date hereof, and InterMune assumes no obligation to update any such forward-looking statements or information. InterMune's actual results could differ materially from those described in InterMune's forward-looking statements.

Factors that could cause or contribute to such differences include, but are not limited to, those discussed in detail under the heading "Risk Factors" in InterMune's most recent annual report on Form 10-K filed with the SEC on March 14, 2008 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) risks related to the long, expensive and uncertain clinical development and regulatory process, including having no unexpected safety, toxicology, clinical or other issues or delays in anticipated timing of the regulatory approval process; (ii) risks related to failure to achieve the clinical trial results required to commercialize our product candidates; and (iii) risks related to timely patient enrollment and retention in clinical trials. The risks and other factors discussed above should be considered only in connection with the fully discussed risks and other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web site at http://www.intermune.com.

Pegasys(R) and Copegus(R) are registered trademarks of Roche


'/>"/>
SOURCE InterMune, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. InterMune Announces Start of Phase 1b Trial of ITMN-191
2. InterMune Announces Approval of Clinical Trial Authorization for Phase 1b Trial of ITMN-191
3. Bionovo Announces Publication of the Paper Detailing the Mechanism of Action of Its Cancer Drug BZL101
4. Kingfisher Announces FDA 510(k) Clearance of Breakthrough KFH Energy for Chronic Pain Sufferers
5. Genaera Corporation Announces MSI-1436 Data Presented at Society of Neuroscience Meeting
6. Keryx Biopharmaceuticals Announces Termination of SUN-MACRO Phase 4 Trial
7. Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update
8. Cystic Fibrosis Foundation Announces Positive Early Results for Phase 2 Clinical Trial of VX-770 - an Oral Compound to Treat CF
9. Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin
10. Nventa Announces Positive Interim Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial
11. Anacor Pharmaceuticals Announces Positive Results from Phase 2a Clinical Trial of AN2728 in Psoriasis Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... FORT WORTH, Texas , May 22, 2015 ... at $58.4 million in 2014 and is estimated to reach ... 2014 to 2019. Browse through the TOC of ... trends and segments, with the help of various tables and ... buyers will receive 10% customization on this report.   ...
(Date:5/22/2015)... ROCKVILLE, Md. , May 22, 2015 /PRNewswire/ ... "RegeneRx") today announced a peer-reviewed publication of the ... study evaluating RGN-259 (RegeneRx,s preservative-free eye drops) for ... Inc.,s controlled adverse environment (CAE ® ) model.  ... and the results, which were previously disseminated by ...
(Date:5/22/2015)... 22, 2015   InspireMD, Inc. (NYSE MKT: NSPR) ... systems ("EPS"), today announced that its CGuard TM Embolic ... investigator Prof. Piotr Musialek , at the EuroPCR ... France . PARADIGM, an investigator-initiated P ... A roti D revascularization I n symptomatic and ...
Breaking Medicine Technology:North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 2North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 2Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 4InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 2InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 3InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 4
(Date:5/24/2015)... (PRWEB) May 24, 2015 ... System CEO - The students ... honored at the fourth annual A ... 15 at Geneva National in Lake ... ,     -Badger High School,         Jonathan Alfonso, ...
(Date:5/23/2015)... San Diego, CA (PRWEB) May 23, 2015 ... businesses, especially small businesses, are finding it increasingly difficult ... Those businesses which fail to provide adequate insurance for ... healthcare for businesses been such an integral part of ... provide more affordable healthcare for businesses, Online USA Doctors ...
(Date:5/23/2015)... Javon Bea Mercy Health System ... and Rehabilitation Center, 557 N. Washington St., Janesville, will ... 20, 5:30-6:30 pm. , The 8-week clinic is lead ... RN, BSN, who will offer training that encompasses a ... mechanics and show selection and weekly training plans. , ...
(Date:5/22/2015)... CA (PRWEB) May 22, 2015 The ... two exciting events in June. They will hold a ... Doctorate and a two-day class on Classical Chinese Medicine. ... June 3, Dr. Steve Given, the Dean of Clinical ... discuss the new First Professional Doctorate program. ACTCM is ...
(Date:5/22/2015)... Pa. (PRWEB) May 22, 2015 Omar ... been selected to participate in the 2015 Congress of ... is described as a gathering of “America’s highest achieving ... new areas of healthcare, set new goals and learn ... include a live surgery, during which we can ask ...
Breaking Medicine News(10 mins):Health News:Mercy Foundation Honors 16 Students for Making a Difference - Mercy Health System Javon Bea 2Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 2Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 3Health News:ACTCM Announces Upcoming June Events 2Health News:Milton Hershey School Student Chosen for Congress of Future Medical Leaders 2
... Calif., Dec. 1 diaDexus, Inc. today,announced that it received ... for Lp-PLA2. This automated format of the PLAC(R) Test, capable ... also cleared by,the U.S. Food & Drug Administration (FDA) in ... Marked PLAC Test to Europe. , ...
... of farm workers are three times as likely as ... other poor children to be uninsured, according to a ... & Adolescent Medicine, one of the JAMA/Archives journals. , ... challenges, according to background information in the article. Most ...
... between groups of immigrants in Oslo. Compared with Norwegians, the ... factors and actual diseases. This is shown in a new ... the largest immigrant groups were compared with each other and ... to target health care better. , The five immigrant ...
... in Federal Court to Reclaim Overtime Pay , ... Riverside County, including the Riverside County Regional Medical Center, filed a ... to stop the county from violating federal law governing hourly wages. ... seeking to represent all 867 registered nurse members of SEIU 721, ...
... Utah, Dec. 2 Smile Reminder, the nation,s ... industry,technology today at Javits Center in New York ... distributing video testimonials can be used to easily ... YouTube, Google,Videos and Yahoo! Video. This new tool ...
... Dec. 2 Are you unhappy with your smile but aren,t sure ... The Pennsylvania Dental Association (PDA) reminds consumers that many cosmetic options ... and dental history to determine a suitable option to help restore your ... , , , ...
Cached Medicine News:Health News:diaDexus Receives CE Mark Certification for the PLAC(R) Test 2Health News:1/3 of farm workers' children lack health insurance 2Health News:Large health differences between population groups in Norway 2Health News:Large health differences between population groups in Norway 3Health News:Large health differences between population groups in Norway 4Health News:Riverside County Registered Nurses File a Lawsuit to Stop County's Violation of Federal Law 2Health News:Doctors Go Viral: vSling Video Testimonial Tool Offers Doctors Access to New Channels for Acquiring Patients 2Health News:Doctors Go Viral: vSling Video Testimonial Tool Offers Doctors Access to New Channels for Acquiring Patients 3Health News:Cosmetic Dentistry: A Beautiful Smile Is Not Far Away 2
... temporary internal drainage from the ureteropelvic junction ... stricture. The segment with no sideports prevents ... preventing ingrowth of the ureteral wall to ... Intended for one-time use. CAUTION: Periodic evaluation ...
Since first designed by Dr. Roy P. Finney in 1978, ACMI™ Classic Ureteral Stents remain the standard for comfort, performance, and quality....
... retrograde or antegrade ureteral ... stent placement. The RB ... band on the delivery ... fluoroscopic visualization during placement. ...
... Used for interoperative placement to ... conduit construction and continent urinary ... packages. Intended for one-time use. ... stent must not remain indwelling ...
Medicine Products: